Effect of acute hepatic encephalopathy on [3 H]dopamine release from rat cerebral cortex and striatum in vitro: role of Ca2plus

• Autorzy: Borkowska H D , Oja S.S. , Hilgier W. , Saransaari P. , Albrecht J.
• Języki publikacji: EN

Abstrakty

EN

Hepatic encephalopathy (HE) is characterized by motor symptoms associated with disturbed functions of the dopaminergic systems, but the underlying mechanisms are not clear. A previous study from our laboratories revealed that HE, induced in rats by repeated treatment with thioacetamide, enhanced the 50 mM potassium (KC1) -stimulated release of newly loaded [3H]dopamine in both striatal and frontal cerebral cortical slices in the presence of Ca2+. In the present study we compared the effects of HE on dopamine release in striatal and frontal cerebral cortical slices and synaptosomes in the presence and absence of Ca2+. HE enhanced the KCl-stimulated [3H]dopamine release from striatal and frontal cortical synaptosomes in the presence of Ca2+ to the same extent as in slices prepared from the respective brain regions. In the absence of Ca2+ a slight reduction in dopamine release was observed in frontal cortical synaptosomes from HE rats when compared to control rats, while no effect of HE on the release was discernible in frontal cortical and striatal slices and striatal synaptosomes. We conclude that in both brain regions studied HE stimulates dopamine exocytosis triggered by Ca2+ influx without affecting the release mediated by means of plasma membrane transporters or exocytosis involving intraterminal Ca2+.

Słowa kluczowe

EN

brain; certain brain region; hepatic encephalopathy; exocytosis; frontal cortex; slice; striatum; dopaminergic system; plasma membrane; dopamine release; cerebral cortex; nitric oxide; potassium stimulus; extracellular accumulation; neurotransmitter; extracellular calcium; synaptosome

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2000
• Tom: 60
• Numer: 1
• Opis fizyczny: p.1-7,fig.

Twórcy

autor

Borkowska H D

• Polish Academy of Science, 5 Pawinski St., 02-106 Warsaw, Poland

autor

Oja S.S.

autor

Hilgier W.

autor

Saransaari P.

autor

Albrecht J.

Bibliografia

• Albrecht J., Hilgier W., Walski M. (1994) Ammonia added in vitro, but not moderate hyperammonemia in vivo, stimulates glutamate uptake and H+-ATPase activity in synaptic vesicles of the rat brain. Metab. Brain Dis. 9: 257-266.
• Aliaga E., Bustos G., Gysling K. (1995) Release of endogen­ous catecholamines from the striatum and bed nucleus of stria terminalis evoked by potassium and N-methyl-D-as- partate: in vitro microdialysis studies. J. Neurosci. Res. 40: 89-98.
• Baizer L., Weiner N. (1985) Regulation of dopamine release from PC 12 pheochromocytoma cell cultures during stimu- lation with elevated potassium or carbachol. J. Neurochem. 44: 495-501.
• Bergeron M., Reader T. A., Layrarques G.P., Butterworth R.F. (1989) Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem. Res. 9: 853-859.
• Bergeron M., Swain M.S., Reader T.A., Butterworth R.F. (1995) Regional alterations of dopamine and its metabo­lites in rat brain following portacaval anastomosis. Neu­rochem. Res. 20: 79-86.
• Borkowska H.D., Oja S.S., Oja O.S., Saransaari P., Hilgier W., Albrecht J. (1999) N-Methyl-D-aspartate-evoked changes in the striatal extracellular levels of dopamine me­tabolites in vivo in rats with acute hepatic encephalopathy. Neurosci. Lett. 268: 151-154.
• Borkowska H.D., Oja S.S., Saransaari P., Albrecht J. (1997) Release of [ H]dopamine from striatal and cerebral cortical slices from rats with thioacetamide-induced hepatic ence­phalopathy: different responses to stimulation by potas­sium ions and agonists of ionotropic glutamate receptors. Neurochem. Res. 22: 101-106.
• Bowyer J.F., Masserano J.M., Weiner N. (1987) Inhibitory ef­fects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes. J. Pharmacol. Exp. Ther. 240: 177-186.
• Carvalho C.M., Ferreira I.L., Duarte C.B., Malva J.O., Tretter L., Adam-Vizi V., Carvalho A.P. (1995) Relation of [Ca2+i] to dopamine release in striatal synaptosomes: role of Ca2+ channels. Brain Res. 669: 234-244.
• Crespi D., Mennini T., Gobbi M. (1997) Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release in­duced by (+)-amphetamine, 3,4-methylendioxymetham- phetamine, p-chloroamphetamine and (+)-fenfluramine. Br. J.Pharmacol. 121: 1735-1743.
• Faff L., Reichenbach A., Albrecht J. (1996) Ammonia-in­duced taurine release from cultured rabbit Mliller cells is an osmoresistant process mediated by intracellular ac­cumulation of cyclic AMP. J. Neurosci. Res. 46: 231­238.
• Faff L., Reichenbach A., Albrecht J. (1997) Two modes of stimulation by ammonia of taurine release from cultured rabbit Muller cells. Neurochem. Int. 31: 301-305.
• Giorguieff M.F., Kernel M.L., Głowiński J. (1977) Presynap­tic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci. Lett. 6: 73-77.
• Girbe F., Ramassamy C., Piton C., Costentin J. (1994) Ascor­bic acid increases synaptosomal potassium-induced do­pamine release. Neuroreport 5: 1027-1029.
• Hilgier W., Olson J.E. (1994) Brain ion and amino acid con­tents during edema development in hepatic encephalo­pathy. J. Neurochem 67: 197-204.
• Hilgier W., Zielińska M., Borkowska H.D., Gadamski R., Walski M., Oja S.S., Saransaari P., Albrecht J. (1999) Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of he­patic failure. J. Neurosci. Res. 56: 76-84.
• Hurd Y.L., Ungerstedt U. (1989a) Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. Eur. J. Pharmacol. 166: 261-269.
• Hurd Y.L., Ungerstedt U. (1989b) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol. 166: 251-260.
• Kiss J.P., Hennings E.C., Zsilla G., Vizi E.S. (1999) A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum. Neurochem. Int. 34: 345-350
• Kosenko E., Kaminsky Y., Lopata O., Muravyov N., Kamin- sky A., Hermenegildo C., Felipo V. (1998) Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication. Metab. Brain Dis. 13: 29-41.
• Mousseau D.D., Perney P., Layrargues G.P., Butterworth R.F. (1993) Selective loss of pallidal dopamine D2 receptor den­sity in hepatic encephalopathy. Neurosci. Lett. 162: 192­196.
• Ochi M., Inoue H., Koizumi S., Shibata S., Watanabe S. (1995) Long-term enhancement of dopamine release by high frequency tetanic stimulation via a Af-methyl-D-aspar- tate-receptor-mediated pathway in rat striatum. Neuros­cience 66: 29-36.
• Okada M., Mine K., Fujiwara M. (1990) Differential calcium dependence between the release of endogenous dopamine and noradrenaline from rat brain synaptosomes. J. Neu­rochem. 54: 1947-1952.
• Okayama T., Teruo H., Kagaya A., Yokota N., Yamawaki S. (1998) Effect of dantrolene on K+ and caffeine-induced do­pamine release in rat striatum assessed by in vivo microdia- lysis. Neurochem. Int. 32: 171-176.
• Pluta R., Albrecht J. (1984) Thioacetamide-induced hepatic encephalopathy in the rat. Clinical observations. Neuropa- tol. Pol. 22: 379-384.
• Raiteri M., Cerrito F., Cervoni A.M., Levi G. (1979) Do­pamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208: 195-202.
• Rao V.L.R., Audet R.M., Butterworth R.F. (1995) Increased nitric oxide synthase activities and L-[3H]arginine uptake in brain following portacaval anastomosis. J. Neurochem. 65: 677-678.
• Rao V.L.R., Giguere J.F., Layrargues G.P., Butterworth R.F. (1993) Increased activities of MAOa and MAOb in auto­psied brain tissue from cirrhotic patients with hepatic ence­phalopathy. Brain Res. 621: 349-352.
• Roberts P.J., Anderson S.D. (1979) Stimulatory effect of L- glutamate and related amino acids on [3H]-dopamine re­lease from rat striatum: an in vitro model for glutamate actions. J. Neurochem. 32: 1539-1545.
• Sitges M., Reyes A., Chiu L.M. (1994) Dopamine transporter mediated release of dopamine: role of chloride. J. Neurosci. Res. 39: 11-22.
• Soliakov L., Wonnacott S. (1996) Voltage-sensitive Ca2+ channels involved in nicotinic receptor-mediated [3H]do- pamine release from rat striatal synaptosomes. J. Neu- rochem. 67: 163-170.
• Stewart T.L., Michel A.D., Black M.D., Humphrey P.P. (1996) Evidence that nitric oxide causes calcium-inde­pendent release of [ HJdopamine from rat striatum in vitro. J. Neurochem. 66: 131-137.
• Stout A.K., Woodward J.J. (1994) Differential effects of nitric oxide gas and nitric oxide donors on depolarization-in­duced release of [3H] norepinephrine from rat hippocampal slices. Neuropharmacology 33: 1367-1374.
• Sun P., Kanthasamy A., Yim G.K., Isom G.E. (1995) Inhibi­tion of potassium-stimulated dopamine release by the nitric oxide generator isosorbide dinitrate. Neuropharmacology 34: 205-210.
• Vizi E.S. (1998) Different temperature dependence of carrier- mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release. Neurochem. Int. 33: 359-366.
• Westerink B.H.C., Hofsteede H.M., Damsma G., de Vries, J.B. (1988) The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn- Schmiedebergs Arch. Pharmacol. 337: 373-378.
• Westerink B.H.C., Hofsteede R.M., Tuntler J., de Vries, J.B. (1989) Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of con­scious rats determined by microdialysis. J. Neurochem. 52: 722-729.
• Young A.M.J., Rees K.R. (1998) Dopamine release in the amygdaloid complex of the rat, studied by brain microdia­lysis. Neurosci. Lett. 249: 49-52.
• Zeneroli M.L., Baraldi M., Ventura E., Vezzelli C., Tofanetti, O., Germini, M., Casciarri, I. (1991) Alterations of GABA- A and dopamine D-2 brain receptors in dogs with portal- systemic encephalopathy. Life Sci. 48: 37-50.